Search Within

Jeffrey L Wong

Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
  3. Review (1)
Groups
  1. Department of Medicine (9)
  2. GME, Medicine (9)
  3. Graduate Medical Education (9)
  4. Hematology-Oncology Fellows (9)
  5. Hematologic Malignancies, Division of (8)
  6. Survivorship Research (5)

More Groups

People
  1. David Knorr (5)
  2. Bernard Bochner (3)
  3. Jonathan Rosenberg (3)
  4. Parastoo Dahi (3)
  5. Alvin Goh (2)
  6. Christian Hernandez (2)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (2)
  5. 2018 (2)
Publications
  1. Blood (2)
  2. Expert Opinion on Biological Therapy (1)
  3. Journal of Clinical Oncology (1)
  4. Nature Immunology (1)
  5. Proceedings of the National Academy of Sciences of the United States of America (1)
  6. Science Translational Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (2)
  2. Elsevier Inc. (2)
  3. American Association for the Advancement of Science (1)
  4. American Society of Clinical Oncology (1)
  5. National Academy of Sciences (1)
  6. Nature Publishing Group (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
    Journal Article

    Wong, J. L.; Smith, P.; Angulo-Lozano, J.; Ranti, D.; Bochner, B. H.; Sfakianos, J. P.; Horowitz, A.; Ravetch, J. V.; Knorr, D. A.
    Proceedings of the National Academy of Sciences of the United States of America (2023)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
    Journal Article

    Herati, R. S.; Knorr, D. A.; Vella, L. A.; Silva, L. V.; Chilukuri, L.; Apostolidis, S. A.; Huang, A. C.; Muselman, A.; Manne, S.; Kuthuru, O.; more...
    Nature Immunology (2022)

    Fulltext@MSK | Save
  • Immune reconstitution following high-dose chemotherapy and autologous stem cell transplantation with or without pembrolizumab maintenance therapy in patients with lymphoma
    Journal Article

    Merryman, R. W.; Redd, R.; Jeter, E.; Wong, J. L.; McHugh, K.; Reynolds, C.; Nazzaro, M.; Varden, A.; Brown, J. R.; Crombie, J. L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
    Journal Article

    Garris, C. S.; Wong, J. L.; Ravetch, J. V.; Knorr, D. A.
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma
    Review

    Wong, J. L.; Rosenberg, J. E.
    Expert Opinion on Biological Therapy (2021)

    Fulltext@MSK | Save
  • PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
    Meeting Abstract

    Chen, Y. B.; Armand, P.; Redd, R. A.; Bsat, J.; Merryman, R. W.; Coleman, K.; Herrera, A. F.; Dahi, P. B.; Nieto, Y.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
    Meeting Abstract

    Armand, P.; Chen, Y. B.; Redd, R. A.; Joyce, R. M.; Bsat, J.; Merryman, R. W.; Coleman, K.; Dahi, P. B.; Nieto, Y.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save